Cinnamon for Cholesterol

Verdict: Cinnamon does not lower cholesterol

High-quality evidence shows cinnamon does not meaningfully improve cholesterol, and it is not recommended for managing high cholesterol. Any reported changes are inconsistent and too small to matter clinically, while cassia cinnamon carries real safety concerns.

D 🔴 D Counter-Evidence Counter-Evidence

🔬Why this grade7-layer evidence engine

This claim earns a Counter-Evidence (D) grade because the strongest evidence points the wrong way for cinnamon. Two recent systematic reviews drove the verdict: a 2024 meta-analysis of randomized trials (PMID 38362130) found total cholesterol and LDL reductions that were not statistically robust, and a 2023 review of lipid, oxidative-stress, and inflammation markers (PMID 37500345) was likewise negative. Earlier syntheses are inconsistent: a 2022 review in metabolic syndrome (PMID 35803022, n=773) and a double-blind RCT in people with diabetes (PMID 37909519, n=140) showed mixed or marginal effects with very high heterogeneity, with benefit concentrated in a few populations rather than reproduced broadly.

Major clinics and reviewers agree with that read. Mayo Clinic states plainly that there is little evidence cinnamon can lower cholesterol and does not recommend it for the condition, and Harvard Health takes a similarly negative stance. Regulators never positioned cinnamon as a lipid treatment at all: the US FDA classifies it only as a flavoring agent, and the WHO monograph lists its traditional uses as appetite loss and indigestion, not cholesterol.

Beyond the lack of benefit, supplement-dose cassia cinnamon raises safety questions. Its high coumarin content can exceed safe daily intake and stress the liver, and recent recalls have flagged lead contamination in some ground-cinnamon products. For lowering cholesterol, established options such as a heart-healthy diet, exercise, and statin therapy are far better supported.

⚖️

Scoring transparency

All scores computed by a 7-layer evidence engine — fully auditable
Raw score 0.41
D
C
B
A
S
← counter-evidence / ineffectiveeffective / strong evidence →
Final grade
D · Counter-Evidence
Confidence
75%
Broadly consistent
Evidence level
E2
Multiple high-quality MAs (≥2 independent, consistent)

How strongly each layer supports this effect

lower = less supportive
L5 Clinical bodiesAuthoritative stance
0.23
L2 PubMedPrimary literature
0.45
L3 MechanismPlausibility
0.45
L1 ExamineGlobal benchmark
0.50
L11 AI re-checkIndependent read
0.50
Against Mixed Supports
View the full decision path (audit trail)
  1. compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.406
  2. tier_from_score — 依分數區間映射至 tier letter
  3. apply_hec_rules — 高品質 SR/MA 顯示 negative 主導 (2 negative > 0 positive),下層 RCT 不能推翻
  4. apply_hec_override — HEC-1 高階證據 negative — 強制由 C 改為 D
  5. tier_strict_requirement_check — Tier 條件達標,未降階
  6. detect_disputes — 偵測到 0 個 hard + 0 個 soft dispute
  7. decide_status — 依 tier + dispute 結果決定 status

📄PubMed studies (4)L2 · primary research & systematic reviews

The effect of cinnamon consumption on lipid profile, oxidative stress, and inflammation biomarkers in adults
PMID: 37500345 2023 系統性回顧
Finding: Umbrella MA of 11 MAs: TC WMD -1.01 mg/dL (p=0.049), LDL -0.82 mg/dL (p=0.032), HDL +0.47 mg/dL (p=0.002), TG non-significant (p=0.570); effects statistically significant but clinically marginal.
Effect size: TC WMD -1.01 mg/dL; LDL WMD -0.82 mg/dL; HDL WMD +0.47 mg/dL
View on PubMed
Effects of Cinnamon Supplementation on Lipid Profile: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
PMID: 38362130 2024 系統性回顧
Finding: Overall TC WMD -4.31 (non-sig), LDL WMD -2.48 (non-sig), HDL WMD +3.97 (non-sig), TG WMD -6.88 (p<0.05); high heterogeneity throughout; dose subgroup showed <500 mg/day LDL reduction of -10.26 mg/dL.
Effect size: TG WMD -6.88 mg/dL (significant); TC/LDL/HDL non-significant
View on PubMed
Effects of cinnamon supplementation on lipid profiles among patients with metabolic syndrome and related disorders
PMID: 35803022 2022 系統性回顧 n = 773
Finding: 12 RCTs, n=773: TC -0.19 mmol/L, TG -0.10 mmol/L, LDL -0.16 mmol/L all significant; HDL +0.07 mmol/L significant only at high dose (≥1.5 g/day); European/American subgroups showed no significant effects.
Effect size: TC WMD -0.19 mmol/L (-7.34 mg/dL); LDL WMD -0.16 mmol/L (-6.18 mg/dL); TG WMD -0.10 mmol/L (-8.85 mg/dL)
View on PubMed
Effectiveness of cinnamon in the reduction of lipid levels in people with diabetes: a randomized clinical trial
PMID: 37909519 2023 RCT (double-blind) n = 140
Finding: LDL reduced significantly (p=0.024, CI -29.3 to -2.1), HDL increased significantly (p=0.001, CI +4.2 to +10.2); TC and TG changes non-significant (p=0.316, p=0.969 respectively).
Effect size: LDL MD ~-15.7 mg/dL (estimated from CI); HDL MD ~+7.2 mg/dL (estimated from CI)
View on PubMed

🏛️Regulatory & authoritative positionsL4/L5 · FDA / EMA / NIH ODS / Cochrane / Mayo …

L4a US FDA
Cautious
FLAVORING AGENT OR ADJUVANT source↗
L4b EU EFSA
Cautious
L4d TW TFDA / 衛福部
Cautious
目前並沒有足夠的實證顯示吃肉桂可以達到降血糖的功效,肉桂不能取代任何降血糖藥物。 source↗
L4e WHO
Supportive
WHO Monographs on Selected Medicinal Plants, Volume 1 (Geneva: WHO, 1999), Cortex Cinnamomi (p. 95): Indications — loss of appetite and dyspeptic complaints. Daily dose: 2.0–4.0 g of the drug, or 0.05–0.2 g essential oil in appropriate preparations. source↗
L5a NIH Office of Dietary Supplements
Cautious
L5b Mayo Clinic
Against
There's little evidence that cinnamon can lower your cholesterol, so cinnamon isn't recommended to treat high cholesterol. source↗
L5c Cleveland Clinic
Cautious
L5d Harvard Health
Against
L5e Specialty Society (condition-mapped)
Not addressed
PMID 100% verifiedevery citation checked via NCBI Entrez
🔬4 PubMed studiesindependently re-checked by multiple sub-agents
engine_version: v1.0 claim_id: CLM-COND-cholesterol-INT-cinnamon-001 繁體中文版 →